Skip to content

New Horizon Aircraft HOVR Weighted-average grant date fair value of stock options (in dollars per share)

Weighted-average grant date fair value of stock options (in dollars per share) at other companies

FMC Corporation logo
FMC CorporationFMC
$9.14-29.9%
Kemper logo
KemperKMPR
$21.44+14.0%
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
$17.83-26.8%
Repligen logo
RepligenRGEN
$65.80-18.2%
Utah Medical Products logo
Utah Medical ProductsUTMD
$16.74-15.3%
Achieve Life Sciences logo
Achieve Life SciencesACHV
$3.81+13.7%

Other financials

Income statement

See full
Operating income-$7.6M-114%
Net income-$6.9M-39.6%
EPS (diluted)-$0.16+5.9%

Balance sheet

See full
Cash & equivalents$19.7M+114%
Total debt$89.0K+154%
Total equity$14.1M+102%
Total assets$21.9M+112%

Cash flow

See full
Operating cash flow-$6.8M-160%
CapEx$140.0K+53.8%
Free cash flow-$7.0M-156%

Valuation

See full
Market cap$119.82M+153%
Enterprise value$100.24M+151%

Returns & leverage

See full
Return on equity-297.2%
Debt / equity0.0×
Current ratio14.8×+7.7×

Where this comes from

Reported directly by New Horizon Aircraft in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.

The official record: New Horizon Aircraft’s 10-K, filed August 22, 2025, on SEC EDGAR. View the filing →

Ask your AI about New Horizon Aircraft's weighted-average grant date fair value of stock options (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is New Horizon Aircraft's weighted-average grant date fair value of stock options (in dollars per share)?
New Horizon Aircraft (HOVR) reported weighted-average grant date fair value of stock options (in dollars per share) of $0.61 in Q1 2025.
What does weighted-average grant date fair value of stock options (in dollars per share) mean?
The weighted average fair value per share of stock options granted during the period, calculated at the date of grant. This metric provides insight into the cost burden of equity incentives relative to the company's current share price. It is a primary driver of the non-cash compensation expense reported in financial statements.